UROwebinar: Outstanding challenges in medical treatment of Male LUTS/BPE
Lower urinary tract symptoms (LUTS) are highly prevalent, cause bother and impair quality of life (QoL). LUTS can be divided into storage, voiding and post-micturition symptoms and are often perceived as a normal process of ageing. An increasing awareness of LUTS is warranted to discuss management options that could increase QoL. These include conservative, medical and surgical treatment. In the upcoming webinar, we discuss mono- and combination medical treatment options for male LUTS. We aim to provide different clinical scenarios which should help to understand current pharmacological treatment options according to the EAU guidelines for non-neurogenic male LUTS.
At a glance
Available languages: English
CME: This webinar is accredited with 1 European CME credit (ECMEC®) upon your completion of the questionnaire after attending the live webinar
This educational activity has been funded by GlaxoSmithKline. The educational programme of this online activity has been a collaboration with GlaxoSmithKline, but independently developed and approved by the European School of Urology, the EAU Section of Female and Functional Urology (ESFFU) and the EAU Guidelines.
CL code NP-GBL-UR-WCNT-210002
Date of preparation February 2021